Simply Wall St Financial Health Rating: ★★★★★★

Overview: Imagi International Holdings Limited is an investment holding company operating in financial services, computer graphic imaging (CGI), and entertainment sectors in Hong Kong, with a market cap of HK$2.64 billion.

Operations: Currently, there are no reported revenue segments available for this company.

Market Cap: HK$2.64B

Imagi International Holdings Limited, with a market cap of HK$2.64 billion, operates across financial services and entertainment sectors in Hong Kong. Despite being unprofitable, the company has narrowed its net loss to HK$4.57 million for 2025 from HK$18.67 million the previous year, aided by gains in securities investments and reversal of impairment allowances. The firm maintains a strong cash position with short-term assets significantly exceeding liabilities and no debt on its balance sheet, ensuring over three years of cash runway at current free cash flow levels. Recent leadership changes include Mr. Han Xuyang’s appointment as Chairman, potentially guiding strategic growth initiatives.

• Take a closer look at Imagi International Holdings’ potential here in our financial health report.

• Gain insights into Imagi International Holdings’ past trends and performance with our report on the company’s historical track record.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Youngy Health Co., Ltd. is involved in the manufacture, export, and sale of sauna products in China with a market cap of CN¥3.84 billion.

Operations: No specific revenue segments are reported for Youngy Health Co., Ltd.

Market Cap: CN¥3.84B

Youngy Health Co., Ltd., with a market cap of CN¥3.84 billion, has shown resilience in the sauna products sector despite recent challenges. The company reported Q1 2026 sales of CN¥239.86 million, down from CN¥251.6 million a year ago, while net income also declined to CN¥23.74 million from CN¥30.98 million. However, its financial health remains robust with short-term assets (CN¥1.1 billion) exceeding liabilities and more cash than total debt, indicating strong liquidity management. Earnings have grown consistently over five years at 17.5% annually and are well-supported by operating cash flow covering debt significantly (642%).

• Click here and access our complete financial health analysis report to understand the dynamics of Youngy Health.

• Gain insights into Youngy Health’s historical outcomes by reviewing our past performance report.

Where To Now?

• Embark on your investment journey to our 949 Asian Penny Stocks selection here.

• Curious About Other Options? The end of cancer? These 31 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer’s.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:1780 SEHK:585 and SZSE:300247.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com